GAMMA Investing’s Relmada Therapeutics RLMD Stock Holding History

GAMMA Investing’s Portfolio RLMD Stock Details RLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$284	Buy	+41	New	+$286	﹤0.01%	4054
2024 Q3	–	Sell	-228	Closed	-$684	–	3645
2024 Q2	$684	Sell	228 -341	-60%	-$1.23K	﹤0.01%	3143
2024 Q1	$2.65K	Hold	569	–	–	﹤0.01%	2659
2023 Q4	$2.24K	Buy	+569	New	+$1.69K	﹤0.01%	2541

Other funds holding RLMD

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

GAMMA Investing's RLMD Position: Q2 2026 in Review

GAMMA Investing opened a new position in Relmada Therapeutics (RLMD) in Q2 2026: 41 shares worth $284. The stake represents ﹤0.01% of the portfolio and ranks #4054 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in RLMD as recently as Q2 2024.

GAMMA Investing first reported a position in RLMD in Q4 2023 and has held it in 4 quarters since. The position peaked at $2.65K in Q1 2024. 2 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.

GAMMA Investing held 41 shares of Relmada Therapeutics worth $284 as of Q2 2026.
Relmada Therapeutics was a new GAMMA Investing position in Q2 2026.
Relmada Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #4054 holding.
GAMMA Investing first reported a position in Relmada Therapeutics in Q4 2023 and has held it in 4 quarters since.
GAMMA Investing's Relmada Therapeutics position peaked at $2.65K in Q1 2024.
2 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.